Every day around 300 million people around the world menstruate. And 90% of the period products they use are single use products, which cause waste and pollution. Vyld, a Berlin-based period care company is looking to change that. And they’re looking to change it with seaweed. Vyld’s “Kelpon” tampon as well as all packaging are made from seaweed aka kelp, which is…
AIMA Laboratories (AIMA), a preclinical FemTech company dedicated to developing new products that fill current gaps in gynecological health, is teaming up with Innovative Health Diagnostics (IHD), a CLIA- and FDA-certified lab, to develop and deliver a new and reliable at-home blood test to detect endometriosis. “We’re thrilled to partner with AIMA to offer a service that provides actionable results and allows millions of…
Medical device start-up Hera Biotech has raised $1.9M in seed funding to support the commercialization of MetriDx, the company’s non-surgical diagnostic test for endometriosis. Investors in this round include Coyote Ventures, Stella Angels, Althea Group Ventures, and the Kendra Scott Women’s Entrepreneurial Leadership Institute. Hera Biotech plans to use the new funds to complete an in-patient human clinical study, expand its IP portfolio, and…
US-based femtech startup 28 is on a mission to support those who menstruate adapt their workouts nutrition and other wellness activities to their cycle. The company, which was founded in 1.5 years ago and bootstrapped to date, has now raised $3.2M in seed funding led by Thiel Capital. Other investors participating in the round include Learn Capital, Steel Perlot and private angel…
Medical diagnostics company DotLab has been granted three patents by the United States Patent and Trademark Office for its technology focused on the diagnosis, assessment, and characterization of endometriosis. Via its clinical studies, DotLab has pioneered medical tests enabled by single-stranded, non-coding RNAs called microRNAs in circulating body fluids such as blood and saliva. The inventions embodied in the portfolio of granted…
Myovant Sciences and Pfizer have announced that the U.S. Food and Drug Administration (FDA) has approved MYFEMBREE (relugolix 40 mg, estradiol 1 mg, and norethindrone acetate 0.5 mg) as a one-pill, once-a-day therapy for the management of moderate to severe pain associated with endometriosis in pre-menopausal women, with a treatment duration of up to 24 months. The approval is supported by one-year efficacy and safety data,…
Leading period underwear brand Thinx is launching Thinx Teens, a new line of reusable and sustainable period panties with built-in leak protection, that will be available for as low as $16, a lower price than its predecessor, Thinx BTWN. With the new, lower price, Thinx Teens is one of the most affordable reusable period products for new menstruators. Thinx Teens is now available online…
Aunt Flow is on a mission to change the world one cycle at a time by making organic period products available for free in every public restroom. The company has now raised an 8.5M Series A led by JL Spark with participation from Harlem Capital, CityRock Ventures and Precursor Ventures and women’s health venture fund Amboy Street Ventures. Since 2016, Aunt Flow…
